Synapse - Works

Results (4808)

Nothing to sneeze at: A full-scale computational model of the human influenza virion

Meeting Abstract

Reddy, T.; Shorthouse, D.; Parton, D.; Jefferys, E.; Fowler, P. W.; Chavent, M.; Baaden, M.; Sansom, M. S. P.
Biophysical Journal (2015)

Fulltext@MSK | Save

Phase 3, randomized trial (CheckMate 017) of nivolumab (nivo) vs docetaxel in advanced squamous (SQ) cell non-small cell lung cancer (NSCLC)

Meeting Abstract

Rechamp, K.; Spigel, D. R.; Rizvi, N.; Poddubskaya, E.; West, H.; Eberhardt, W.; Baas, P.; Antonia, S. J.; Pluzanski, A.; Vokes, E. E.; more...
Asia-Pacific Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Updated survival results from a randomized, dose-ranging phase II study of nivolumab (NIVO) in metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Plimack, E. R.; Hammers, H. J.; Rini, B. I.; McDermott, D. F.; Redman, B. G.; Kuzel, T. M.; Harrison, M. R.; Vaishampayan, U. N.; Drabkin, H. A.; George, S.; more...
Asia-Pacific Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Efficacy and safety in key patient subgroups of vivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naive patients with advanced melanoma (MEL) (Checkmate 067)

Meeting Abstract

Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Wagstaff, J.; Hogg, D.; Hill, A.; Carlino, M. S.; more...
Asia-Pacific Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Longer-term follow-up of a phase 2 study (Checkmate 063) of nivolumab in patients with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC)

Meeting Abstract

Horn, L.; Rizvi, N.; Mazieres, J.; Planchard, D.; Stinchcombe, T. E.; Dy, G. K.; Antonia, S. J.; Lena, H.; Minenza, E.; Mennecier, B.; more...
Asia-Pacific Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC)

Meeting Abstract

Calvo, E.; Lopez-Martin, J.; Bendell, J.; Eder, J. P.; Taylor, M.; Ott, P. A.; Pietanza, M. C.; Horn, L.; Jäger, D.; De Braud, F.; more...
Asia-Pacific Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Clinical response, progression-free survival (PFS) and safety in patients (pts) with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI) versus IPI monotherapy in Checkmate 069 study

Meeting Abstract

Hodi, F. S.; Postow, M. A.; Chesney, J.; Pavlik, A. C.; Robert, C.; Grossman, K.; McDermott, D.; Linette, G.; Meyer, N.; Giguere, J. K.; more...
Asia-Pacific Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase 1/2 study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032

Meeting Abstract

Antonia, S. J.; Bendell, J.; Taylor, M.; Calvo, E.; Jäger, D.; De Braud, F.; Ott, P. A.; Pietanza, M. C.; Horn, L.; Le, D. T.; more...
Annals of Oncology (2015)

Fulltext@MSK | Save

CheckMate 067: A phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with ipilimumab (IPI) versus IPI monotherapy in previously untreated patients (pts) with advanced melanoma (MEL)

Meeting Abstract

Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; more...
Annals of Oncology (2015)

Fulltext@MSK | Save

PEGylated human IL-10 (AM0010) in advanced solid tumors

Meeting Abstract

Naing, A.; Infante, J. R.; Papadopoulos, K.; Autio, K.; Ott, P.; Wong, D.; Falchook, G. S.; Patel, M. R.; Pant, S.; Oft, M.
Annals of Oncology (2015)

Fulltext@MSK | Save